1. Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist

   • Matthew A. Cavender
   • A. Michael Lincoff

   Leading Article 17 August 2012 Pages: 209 - 216

   

2. Platelet P2Y₁₂ Receptor Inhibition

   • David Vivas
   • Dominick J. Angiolillo

   Review Article 17 August 2012 Pages: 217 - 226

   

3. Contrast Agents Used in Cardiovascular Magnetic Resonance Imaging

   • John M. Moriarty
   • J. Paul Finn
   • Carissa G. Fonseca

   Review Article 17 August 2012 Pages: 227 - 237

   

4. Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension

   • Dean J. Kereiakes
   • Jen-Fue Maa
   • Robert Dubiel

   Original Research Article 17 August 2012 Pages: 239 - 246

   

5. β-Blockers Reduce Mortality in Patients Undergoing High-Risk Non-Cardiac Surgery

   • Fabio Angeli
   • Paolo Verdecchia
   • Gianpaolo Reboldi

   Original Research Article 17 August 2012 Pages: 247 - 259

   

6. Retrospective Review of Digoxin Exposures to a Poison Control System following Recall of Digitek® Tablets

   • Sean Patrick Nordt
   • Alicia Minns
   • Richard F. Clark

   Short Communication 17 August 2012 Pages: 261 - 263

7. Trimetazidine Activates Paraoxonase

   • Goran Pante Koracevic
   • Tatjana Cvetkovic
   • Maja Koracevic

   Correspondence 17 August 2012 Pages: 265 - 266

8. Anacetrapib

   Adis R&D Profile 17 August 2012 Pages: 267 - 270

   

9. Mipomersen

   Adis R&D Profile 17 August 2012 Pages: 271 - 279